Filtered By:
Vaccination: Cervical Cancer Vaccine
Countries: India Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 154 results found since Jan 2013.
Evaluation of the Therapeutic Effect of Quadrivalent Human Papillomavirus (HPV) Vaccination on Cervical Intraepithelial Neoplasia Lesions
Indian J Surg Oncol. 2023 Jun;14(2):504-509. doi: 10.1007/s13193-022-01657-w. Epub 2022 Oct 1.ABSTRACTCervical cancer is the most common health problem among global young women. Cervical intraepithelial neoplasia (CIN) is a pre-invasive stage of cervical cancer, the major cause of which is human papillomavirus (HPV), and vaccination has a promising effect on reducing the progression of CIN lesions. The current study was a retrospective case control investigation in two centers, Shiraz and Sari Universities of Medical Sciences from 2018 to 2020 to evaluate the effect of quadrivalent HPV vaccination on CIN lesions (I, II, an...
Source: Cancer Control - June 16, 2023 Category: Cancer & Oncology Authors: Zahra Shiravani Zinab Nazari Freshteh Yazdani Fatemeh Sadat Najib Mojgan Akbarzadeh Jahromi Mozhdeh Momtahan Sara Pourseyed Shaghayegh Moradialamdarloo Mojgan Hajisafari Tafti Source Type: research
Epidemiology of human papillomavirus related cancers in India: findings from the National Cancer Registry Programme
Ecancermedicalscience. 2022 Sep 7;16:1444. doi: 10.3332/ecancer.2022.1444. eCollection 2022.ABSTRACTHuman papillomavirus (HPV) causes more than one-fourth of infection related cancers globally. The present study summarises the epidemiology of HPV related cancers in India, with a special focus on cervical and oropharyngeal cancer, utilising the National Cancer Registry Programme (NCRP) data. The data on HPV related cancer incidence and treatment were extracted from 28 population-based and 96 hospital-based cancer registries under the NCRP network. Incidence was presented as rates, clinical extent of disease and treatment pr...
Source: Cancer Control - November 21, 2022 Category: Cancer & Oncology Authors: Thilagavathi Ramamoorthy Krishnan Sathishkumar Priyanka Das Kondalli Lakshminarayana Sudarshan Prashant Mathur Source Type: research
Reaching the "Hard-to-Reach" Sexual and Gender Diverse Communities for Population-Based Research in Cancer Prevention and Control: Methods for Online Survey Data Collection and Management
CONCLUSION: Study findings showcase effective strategies to reach communities, maximize data quality, and prevent the misrepresentation of data critical to improve health in SGD communities.PMID:35756657 | PMC:PMC9213655 | DOI:10.3389/fonc.2022.841951
Source: Cancer Control - June 27, 2022 Category: Cancer & Oncology Authors: Katie J Myers Talya Jaffe Deborah A Kanda V Shane Pankratz Bernard Tawfik Emily Wu Molly E McClain Shiraz I Mishra Miria Kano Purnima Madhivanan Prajakta Adsul Source Type: research
Screening technologies for cervical cancer: Overview
Cytojournal. 2022 Mar 29;19:23. doi: 10.25259/CMAS_03_04_2021. eCollection 2022.ABSTRACTEver since the introduction of the Papanicolaou (PAP) smear test was published in 1941 in American Journal of Obstetrics and Gynecology, PAP test linked with definitive treatment has prevented millions of women from cervical cancer in the developed countries. Due to limited availability of resources, a lack of infrastructure and difficulty in getting highly trained professionals, widespread implementation of PAP test dependent cervical cancer screening program has not been established in low and middle income countries such as India. Th...
Source: Cancer Control - May 5, 2022 Category: Cancer & Oncology Authors: Dipanwita Banerjee Srabani Mittal Ranajit Mandal Partha Basu Source Type: research
Barriers and Factors Associated with HPV Vaccination Among American Indians and Alaska Natives: A Systematic Review
AbstractAmerican Indian and Alaska Native (AI/AN) persons bear a disproportionate burden of human papillomavirus (HPV)-associated cancers and face unique challenges to HPV vaccination. We undertook a systematic review to synthesize the available evidence on HPV vaccination barriers and factors among AI/AN persons in the United States. We searched fourteen bibliographic databases, four citation indexes, and six gray literature sources from July 2006 to January 2021. We did not restrict our search by study design, setting, or publication type. Two reviewers independently screened the titles and abstracts (stage 1) and full-t...
Source: Journal of Community Health - February 24, 2022 Category: International Medicine & Public Health Source Type: research
Missed opportunities for human papillomavirus vaccine series initiation in a large, rural U.S. state
Hum Vaccin Immunother. 2022 Feb 4:1-5. doi: 10.1080/21645515.2021.2016304. Online ahead of print.ABSTRACTHuman papillomavirus (HPV) vaccination rates are lower in rural versus urban areas of the United States. Our objective was to identify the types of vaccination clinic settings where missed opportunities for HPV vaccine series initiation most frequently occurred in Montana, a large, primary rural U.S. state. We analyzed a limited dataset from Montana's immunization information system for adolescents who turned 11 years old in 2014-2017. Vaccination visits where the HPV vaccine was due but not administered were missed opp...
Source: Cancer Control - February 4, 2022 Category: Cancer & Oncology Authors: Sophia R Newcomer Rain E Freeman Alexandria N Albers Sara Murgel Juthika Thaker Annie Rechlin Bekki K Wehner Source Type: research
Covax, the Developing World ’ s Hope against COVID, Has Made It Only Halfway
Delivery of syringes for the vaccination campaign in El Salvador. Latin American countries have made steady progress in immunizing their populations, partly through direct negotiations between their governments and suppliers and partly through international cooperation. CREDIT: PAHO
By Humberto MárquezCARACAS, Jan 20 2022 (IPS) The Covax initiative, the hope of the countries of the developing South to immunize their populations against COVID-19, only met half of its goals in 2021. And as 2022 begins, and the omicron variant of the virus is spreading fast, the scheme still depends on the decisions of pharmaceutical compani...
Source: IPS Inter Press Service - Health - January 20, 2022 Category: International Medicine & Public Health Authors: Humberto Marquez Tags: COVID-19 Development & Aid Editors' Choice Featured Global Global Governance Headlines Health Humanitarian Emergencies Regional Categories TerraViva United Nations COVAX COVID-19 vaccines Source Type: news
E6-E7 based nested multiplex PCR assay for genital HPV detection and simultaneous typing of 15 high and low-risk HPV types
CONCLUSIONS: The designed nested PCR based assay had good concordance with clinical histology and sequencing results and appears to be a promising tool for HPV genotyping especially in resource-constrained settings.PMID:34871707 | DOI:10.1016/j.ijmmb.2021.11.009
Source: Cancer Control - December 6, 2021 Category: Cancer & Oncology Authors: Nagaraja Mudhigeti Usha Kalawat Narendra Hulikal Rishi Gowtham Racherla Source Type: research
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial
Vaccine. 2021 Nov 29:S0264-410X(21)01486-9. doi: 10.1016/j.vaccine.2021.11.041. Online ahead of print.ABSTRACTHPV vaccination of adolescent girls is the most effective measure to prevent cervical cancer. The World Health Organization recommends that adolescent girls receive two doses of vaccine but only a small proportion of girls from regions with the highest disease burden are vaccinated because of cost and logistical considerations. Our Costa Rica HPV Vaccine trial suggested that one dose of the bivalent HPV vaccine provides robust and lasting protection against persistent HPV infections for over a decade. Data from a p...
Source: Vaccine - December 3, 2021 Category: Allergy & Immunology Authors: Carolina Porras Joshua N Sampson Rolando Herrero Mitchell H Gail Bernal Cort és Allan Hildesheim Jean Cyr Byron Romero John T Schiller Christian Montero Ligia A Pinto John Schussler Karla Coronado M ónica S Sierra Jane J Kim Catherine M Torres Loretto C Source Type: research
Screening for cervical cancer: Choices & amp; dilemmas
Indian J Med Res. 2021 Dec 2. doi: 10.4103/ijmr.IJMR_857_20. Online ahead of print.ABSTRACTCervical cancer is the fourth most common cancer in women in the world. To eliminate cervical cancer by 2030, the World Health Organization has given the target of 70 per cent coverage of twice lifetime screening. A multitude of screening methods are available, including cytology, human papillomavirus (HPV) DNA testing and visual inspection tests. Precision tests, including molecular and protein biomarkers such as DNA methylation, p16 immunostaining, and HPV mRNA testing help to enhance specificity of the screening. Worldwide HPV DNA...
Source: The Indian Journal of Medical Research - December 2, 2021 Category: Biomedical Science Authors: Shalini Rajaram Bindiya Gupta Source Type: research
